Curis (CRIS) Other Accumulated Expenses (2011 - 2016)
Curis' (CRIS) quarterly Other Accumulated Expenses came in at $226000.0 in Q2 2016, up 17.92% YoY from $191659.0 in Q3 2015, and up 17.61% on a QoQ basis from $192164.0 in Q1 2016.
Curis (CRIS) Other Accumulated Expenses (2011 - 2016) Analysis & Trends
Curis (CRIS) has 6 years of Other Accumulated Expenses data on file, last reported at $226000.0 in Q2 2016.
- Quarterly Other Accumulated Expenses rose 17.92% year-over-year to $226000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $226000.0 (up 17.92% YoY) and the FY2015 annual result came in at $249000.0, up 17.15% from the prior year.
- Other Accumulated Expenses climbed to $226000.0 in Q2 2016, from $192164.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $249000.0 in Q4 2015 to a low of $115518.0 in Q2 2012.
- A 5-year average of $183073.9 and a median of $188862.0 in 2015 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2013 — Other Accumulated Expenses surged 86.06% — and 2014, when it decreased 22.71%.
- Tracing CRIS's Other Accumulated Expenses over 5 years: stood at $143851.0 in 2012, then climbed by 24.01% to $178390.0 in 2013, then rose by 19.15% to $212548.0 in 2014, then rose by 17.15% to $249000.0 in 2015, then declined by 9.24% to $226000.0 in 2016.
- The last three Other Accumulated Expenses figures came in at $226000.0 (Q2 2016), $192164.0 (Q1 2016), and $249000.0 (Q4 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 226,000.00 |
| Mar 31, 2016 | 192,164.00 |
| Dec 31, 2015 | 249,000.00 |
| Sep 30, 2015 | 186,670.00 |
| Jun 30, 2015 | 191,659.00 |
| Mar 31, 2015 | 188,862.00 |
| Dec 31, 2014 | 212,548.00 |
| Sep 30, 2014 | 195,116.00 |
| Jun 30, 2014 | 166,116.00 |
| Mar 31, 2014 | 207,022.00 |
| Dec 31, 2013 | 178,390.00 |
| Sep 30, 2013 | 134,527.00 |
| Jun 30, 2013 | 214,937.00 |
| Mar 31, 2013 | 160,020.00 |
| Dec 31, 2012 | 143,851.00 |
| Sep 30, 2012 | 149,857.00 |
| Jun 30, 2012 | 115,518.00 |
| Dec 31, 2011 | 166,037.00 |